ALLURION TECHNOLOGIES, INC. (ALUR): Nasdaq/NYSE listing notice — Allurion receives NYSE delisting notice for non-compliance with equity/market cap standard; intends to appeal

ALLURION TECHNOLOGIES, INC.

NYSE notified Allurion it fails Section 802.01B: requires ≥$50M stockholders' equity or ≥$50M market cap on 30-day average.
Company intends to appeal; shares expected to continue trading on NYSE during the appeal process.
Recent FDA approval on Feb 20, 2026 cited as catalyst for regaining compliance or relisting on another exchange.
Also pursuing debt-for-preferred exchange with largest creditor and completed warrant inducement on Feb 24, 2026.
No guarantee of success; risk of delisting and negative impact on liquidity and capital access if appeal fails.

item 3.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ALLURION TECHNOLOGIES, INC. received a nyse delisting notice notice regarding other (rules 802.01B).

Exchange: nyse
Notice: delisting notice
Rules: 802.01B

Exact text from the filing

March 2, 2026, Allurion Technologies, Inc., a Delaware corporation (the “Company”) announced that it received a letter (the “Delisting Notice”) from the staff of the New York Stock Exchange (the “Exchange” or “NYSE”) indicating that the Company does not meet certain of the Exchange’s continued listing standards as set forth in Section 802.01B of the NYSE Listed Company Manual that require listed companies to maintain either (i) at least $50 million in stockholders’ equity or (ii) at least $50 million in total market capitalization on a 30-trading day average basis and that the Exchange will be

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

ALLURION TECHNOLOGIES, INC. filing history →

Source: SEC EDGAR

accession 0001193125-26-084412

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.